Oxford Biodynamics Plc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Oxford Biodynamics Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014235
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Oxford Biodynamics Plc (Oxford Biodynamics) is a biotechnology company that discovers and develops biomarker discovery platform. The company concentrates on research in detection, monitoring and prognosis of major diseases associated with aberrant gene expression such as oncology, metabolic, inflammatory, cardiovascular and neurodegenerative conditions. Its biomarker discovery platform is used for the detection of aberrant gene expression. The company’s products are used in the areas of breast cancer diagnostics, hepatocellular carcinoma diagnostics, nasopharyngeal carcinoma diagnostics, prostate cancer progression, melanoma diagnostics, and age related disease diagnostics. Oxford Bio is headquartered in Oxford, the UK.

Oxford Biodynamics Plc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Oxford Biodynamics Plc, Medical Devices Deals, 2011 to YTD 2017 9
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Oxford Biodynamics Raises US$3.2 Million In Financing 11
Partnerships 12
Oxford BioDynamics Enters into Agreement with US Biopharma Company 12
Oxford Biodynamics Enters into Development Agreement with Two Pharmaceutical Companies 13
Equity Offering 14
Oxford BioDynamics Raises USD24.9 Million in Issue of New Ordinary Shares 14
Oxford Biodynamics Plc – Key Competitors 15
Oxford Biodynamics Plc – Key Employees 16
Oxford Biodynamics Plc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Jun 13, 2017: Oxford Biodynamics Interim Results For The Six-Month Period Ended 31 March 2017 18
Jan 31, 2017: Oxford BioDynamics Announces Final Results for the Year Ended 30 September 2016 24
Corporate Communications 26
Sep 15, 2017: Oxford BioDynamics appoints Paul Stockdale as Chief Financial Officer and Executive Director on the Board 26
Jun 30, 2017: Oxford BioDynamics: Appointment of Paul Stockdale as Chief Financial Officer 27
Mar 09, 2017: Oxford BioDynamics announces appointment of Martin Reeves as Senior Vice President of Commercial Development 28
Feb 13, 2017: Oxford BioDynamics appoints Dr Claudio Carini as an Advisor 29
Government and Public Interest 30
Mar 17, 2017: Oxford BioDynamics announces collaboration to identify biological factors that trigger disease relapses in Rheumatoid Arthritis 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Key Facts 2
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Oxford Biodynamics Plc, Deals By Therapy Area, 2011 to YTD 2017 8
Oxford Biodynamics Plc, Medical Devices Deals, 2011 to YTD 2017 9
Oxford Biodynamics Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Oxford Biodynamics Raises US$3.2 Million In Financing 11
Oxford BioDynamics Enters into Agreement with US Biopharma Company 12
Oxford Biodynamics Enters into Development Agreement with Two Pharmaceutical Companies 13
Oxford BioDynamics Raises USD24.9 Million in Issue of New Ordinary Shares 14
Oxford Biodynamics Plc, Key Competitors 15
Oxford Biodynamics Plc, Key Employees 16
Oxford Biodynamics Plc, Other Locations 17

★海外企業調査レポート[Oxford Biodynamics Plc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hays plc (HAS):企業の財務・戦略的SWOT分析
    Hays plc (HAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • EZCORP Inc (EZPW):企業の財務・戦略的SWOT分析
    EZCORP Inc (EZPW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Noble Corporation Plc (NE):企業の財務・戦略的SWOT分析
    Noble Corporation Plc (NE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • San Miguel Corporation:企業のM&A・事業提携・投資動向
    San Miguel Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's San Miguel Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Reviva Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Reviva Pharmaceuticals Inc (Reviva Pharma) is a clinical development pharmaceutical company that develops therapeutic drugs. The company develops drugs in the therapeutic areas of cardiovascular, metabolic, central nervous system and inflammatory diseases. Its product pipeline comprises RP50 …
  • Swiss Life Holding Ltd:企業の戦略・SWOT・財務情報
    Swiss Life Holding Ltd - Strategy, SWOT and Corporate Finance Report Summary Swiss Life Holding Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Thoresen Thai Agencies Public Company Limited:企業の戦略・SWOT・財務分析
    Thoresen Thai Agencies Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Thoresen Thai Agencies Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Lee Enterprises Inc (LEE):企業の財務・戦略的SWOT分析
    Lee Enterprises Inc (LEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Dollar Tree Inc:企業の戦略・SWOT・財務情報
    Dollar Tree Inc - Strategy, SWOT and Corporate Finance Report Summary Dollar Tree Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Caribbean Utilities Company, Ltd.:発電所・企業SWOT分析
    Caribbean Utilities Company, Ltd. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Main Street America Insurance Company:企業の戦略的SWOT分析
    Main Street America Insurance Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Ypsomed Holding AG (YPSN):医療機器:M&Aディール及び事業提携情報
    Summary Ypsomed Holding AG (Ypsomed) is a medical device company that designs, develops and manufactures injection and infusion systems for self-medication and offers related services. It offers autoinjectors, dual chamber pens, and pen injectors. The company also offers services ranging from design …
  • Boardwalk Pipeline Partners LP:企業の戦略・SWOT・財務分析
    Boardwalk Pipeline Partners LP - Strategy, SWOT and Corporate Finance Report Summary Boardwalk Pipeline Partners LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • BB&T Corporation:企業の戦略・SWOT・財務情報
    BB&T Corporation - Strategy, SWOT and Corporate Finance Report Summary BB&T Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • BioLineRx Ltd (BLRX)-医療機器分野:企業M&A・提携分析
    Summary BioLineRx Ltd (BioLineRx) is a clinical stage biopharmaceutical company that focuses on the identification, in-licensing, and development of products to address unmet medical needs. The company’s product pipeline includes BL-8040, a short peptide for multiple cancer and hematological indicat …
  • Telenor ASA:企業の戦略・SWOT・財務情報
    Telenor ASA - Strategy, SWOT and Corporate Finance Report Summary Telenor ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Psychemedics Corp (PMD):企業の財務・戦略的SWOT分析
    Summary Psychemedics Corp (Psychemedics) is a clinical laboratory service provider. The company provides testing for drugs abuse using hair analysis. It offers drug panel, workplace drug testing, personal drug testing kits, school drug testing, alcohol testing, synthetic cannabinoids testing, benzod …
  • Big Lots, Inc.:企業の戦略・SWOT・財務情報
    Big Lots, Inc. - Strategy, SWOT and Corporate Finance Report Summary Big Lots, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Soitec SA (SOI):企業の財務・戦略的SWOT分析
    Soitec SA (SOI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Alstom SA (ALO):企業の財務・戦略的SWOT分析
    Alstom SA (ALO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆